Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

IQVIA Holdings (IQV)

NYSE: IQV · Diagnostics & Research · Durham, NC

Our rating: Positive

Call changed from Neutral to Positive at $279.04, moderate conviction, October 28, 2026.

Breaks if: The Positive call breaks if revenue growth slows to below 3% for two consecutive reported quarters, or if trailing twelve-month free cash flow drops below $2.1B in any of the next four quarterly filings — either would indicate that durable growth and cash conversion, the two pillars of the thesis, are eroding faster than the current price assumes.

Key figures

Market value$40.5B
Revenue, last 12 months$17.3B
Net income, last 12 months$1.4B
Free cash flow, last 12 months$2.1B
Price to earnings29.1×
Free cash flow yield5.1%
Dividend yield0.0%
Operating margin12.8%
Return on equity21.7%
Beta to the S&P 5000.92
Volatility, annualized37.9%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$4.4B8.0%$2.10$667M
June 30, 2026$4.4B8.7%$1.53$360M
March 31, 2026$4.2B8.4%$1.61$491M
December 31, 2025$4.4B10.3%$2.98$561M
September 30, 2025$4.1B5.2%$1.93$772M
June 30, 2025$4.0B5.3%$1.54$292M
March 31, 2025$3.8B2.5%$1.40$426M
December 31, 2024$4.0B2.3%$2.41$721M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

14 ledger entries and 72 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.